- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lipigon Pharmaceuticals AB (LPGO)
Lipigon Pharmaceuticals AB stock price live, this page displays ST LPGO stock exchange data. View the LPGO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lipigon Pharmaceuticals AB real time stock price chart below.
What Is the Lipigon Pharmaceuticals AB Stock Price Today?
The Lipigon Pharmaceuticals AB stock price today is 0.184.
What Is the Stock Symbol for Lipigon Pharmaceuticals AB?
The stock symbol for Lipigon Pharmaceuticals AB is ""LPGO.""
What Stock Exchange Does Lipigon Pharmaceuticals AB Trade On?
Lipigon Pharmaceuticals AB is listed and trades on the Stockholm stock exchange.
Is Lipigon Pharmaceuticals AB a Good Stock to Buy?
Determining whether Lipigon Pharmaceuticals AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LPGO quote. (ISIN: SE0015382072)
What Is the Lipigon Pharmaceuticals AB Stock Price Today?
The Lipigon Pharmaceuticals AB stock price today is 0.184.
What Is the Stock Symbol for Lipigon Pharmaceuticals AB?
The stock symbol for Lipigon Pharmaceuticals AB is ""LPGO.""
What Stock Exchange Does Lipigon Pharmaceuticals AB Trade On?
Lipigon Pharmaceuticals AB is listed and trades on the Stockholm stock exchange.
Is Lipigon Pharmaceuticals AB a Good Stock to Buy?
Determining whether Lipigon Pharmaceuticals AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LPGO quote. (ISIN: SE0015382072)
Stockholm
Currency in SEK
0.184
+0.004(+2.22%)
Closed·
Fair Value
An estimate of a Lipigon Pharmaceuticals AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.171
0.184
52 wk Range
0.075
0.370
LPGO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LPGO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Lipigon Pharmaceuticals AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1710.184
52 wk Range
0.0750.370
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LPGO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Lipigon Pharmaceuticals AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Lipigon Pharmaceuticals AB Company Profile
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company’s product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden.
Compare LPGO to Peers and Sector
Metrics to compare | LPGO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLPGOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −9.6x | −0.5x | |
PEG Ratio | 0.09 | −0.20 | 0.00 | |
Price/Book | 0.9x | 6.7x | 2.6x | |
Price / LTM Sales | 2.7x | 42.7x | 3.3x | |
Upside (Analyst Target) | 171.7% | 8.1% | 43.4% | |
Fair Value Upside | Unlock | 6.5% | 7.1% | Unlock |
Earnings
Latest Release
May 22, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
41.00K / --
FAQ
What Stock Exchange Does Lipigon Pharmaceuticals AB Trade On?
Lipigon Pharmaceuticals AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Lipigon Pharmaceuticals AB?
The stock symbol for Lipigon Pharmaceuticals AB is "LPGO."
What Is the Lipigon Pharmaceuticals AB Market Cap?
As of today, Lipigon Pharmaceuticals AB market cap is 27.22M.
What Is Lipigon Pharmaceuticals AB's Earnings Per Share (TTM)?
The Lipigon Pharmaceuticals AB EPS (TTM) is -0.18.
From a Technical Analysis Perspective, Is LPGO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Lipigon Pharmaceuticals AB Stock Split?
Lipigon Pharmaceuticals AB has split 0 times.
How Many Employees Does Lipigon Pharmaceuticals AB Have?
Lipigon Pharmaceuticals AB has 7 employees.
What is the current trading status of Lipigon Pharmaceuticals AB (LPGO)?
As of 10 Aug 2025, Lipigon Pharmaceuticals AB (LPGO) is trading at a price of 0.18, with a previous close of 0.18. The stock has fluctuated within a day range of 0.17 to 0.18, while its 52-week range spans from 0.08 to 0.37.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.